Bioceltix
We develop innovative biopharmaceuticals based on stem cells.
Bioceltix has raised €2.5M across 2 funding rounds from 1 investor, most recently a round in Jan 2024. Based in Warsaw, Poland; founded 2016; active in Healthtech. Data as of 28 Oct 2026.
Total raised
€2.5M
€2,500,000
Funding rounds
2
Investors
1
distinct backers
Active since
2019-10
latest 2024-01
Funding by year
EUR raised per yearBioceltix — funding by year — interactive chart.
Data table
| Bioceltix — funding by year | |
|---|---|
| 2019 | €0 |
| 2024 | €2.5M |
Signals
Medium confidenceRaise-next likelihood6
base rate 30% for Other
- ▼ Past typical raise window
- ▼ Low backer re-investment
Exit likelihood7
base rate 11% (2+ rounds)
- ▲ 10y since founding (typical exit age)
- ▼ No recent equity round (debt-only or quiet)
Timing: overdue vs cohort gap · momentum unknown. Funding-only estimates, not predictions and not investment advice — see signals.
Funding rounds
2 rounds| Date | Stage | Amount | Investors | |
|---|---|---|---|---|
| 2024-01-10 | Other | €2.5M | European Funds for a Modern Economy (FENG) | View deal → |
| 2019-10-01 | Other | €0 | — | View deal → |
Related news
Similar companies
same sector or country- InPost€2.8BPoland · Transportation
- Philips€2.6BNetherlands · Healthtech
- Isomorphic Labs€2.3BUK · Healthtech
- Allegro€2.0BPoland · E-commerce
- CMR Surgical€1.5BUK · Healthtech
- Roivant Sciences€1.1BSwitzerland · Healthtech
Global coverage: FundingData